Man behind GcMAF is facing jail
CREATOR of controversial ‘wonder drug’ GcMAF, David Noakes, faces jail for risking patient safety to pocket millions from the sale of outlawed medicines.
Former Guernsey resident Noakes, 64, is the CEO and beneficial owner of Immuno Biotech Ltd, which has been registered in the island since 2011.
He used the firm to promote products containing GcMAF, made using human blood, and claimed it was a cure for several illnesses and conditions, including cancer, multiple sclerosis, HIV and autism.
But products containing GcMAF are said to present a significant health risk, regulators say.
Noakes appeared at Southwark Crown Court alongside ex-wife and distribution firm director Loraine Noakes to admit charges relating to the manufacture, possession and sale of products, including the drug.
Noakes, now of Waldershare, Dover, Kent, admitted two counts of manufacturing a medicinal product without a manufacturer’s licence, two of selling or supplying medicinal products without market authorisation, and one count of money laundering.
A single count of possessing an unauthorised medical product will lie on file.
Loraine Noakes, 58, of Ringwood, Hampshire, admitted two counts of selling or supplying medicinal products without market authorisation.
Their sentencing is expected to last two days at the same court on 20 and 21 November.
There will be an additional hearing on 19 November.
Immuno Biotech is now registered to an address in St Sampson’s.
The company’s then offices in the Lower Pollet were raided by Guernsey Police on Wednesday 22 February 2017.
The former Health and Social Services Department carried out searches at the same premises and a residential property on 28 January 2016 as part of an investigation into the alleged selling of unlicensed medicines.
However, the Law Officers conceded the execution of that warrant had been unlawful.
Guernsey banned the import of GcMAF in February 2015 after the UK Medicines and Healthcare products Regulatory Agency warned it ‘may pose a significant risk to people’s health’.
The MHRA carried out a raid and shut down a Cambridgeshire manufacturing site.
Criminal investigations into a GcMAF clinic in Switzerland began in July 2015.
Noakes has previously said GcMAF was the best way to treat cancer and 50 other diseases inexpensively and that these products had been both quality and safety-checked.
